Eukaryotic mRNAs possess a methylated 5'-guanosine cap that is required for RNA stability, 23 efficient translation, and protection from cell-intrinsic defenses. Many viruses use 5' caps or 24 other mechanisms to mimic a cap structure to limit detection of viral RNAs by intracellular 25 innate sensors and to direct efficient translation of viral proteins. The coronavirus (CoV) 26 nonstructural protein 14 (nsp14) is a multifunctional protein with N7-methyltransferase (N7-27 MTase) activity. The highly conserved S-adenosyl-L-methionine (SAM)-binding residues of the 28 DxG motif are required for nsp14 N7-MTase activity in vitro. However, the requirement for CoV 29 N7-MTase activity and the importance of the SAM-binding residues during viral replication have 30 not been determined. Here, we engineered mutations in murine hepatitis virus (MHV) nsp14 N7-31
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guanylyltransferase has not been identified but, according to the current model, would function 75 to add a GMP to the diphosphate RNA product of nsp13. The RNA-dependent RNA polymerase 76 (RdRp) of equine arteritis virus and SARS-CoV displays nucleotidylation activity (15). While 77 further study is required to define the function of this activity in viral replication, it is possible 78 that the RdRp participates in CoV RNA capping. Nsp16 of feline coronavirus functions 79 independently as a 2'O-MTase (16-18), but SARS-CoV nsp16 requires nsp10 as a co-factor for 80 2'O-MTase activity. SARS-CoVs lacking 2'O-MTase activity are recognized and sequestered by 81 IFIT1 (13, 19-23) due to the lack of a cap-1 structure. 82
CoV nsp14 is a multifunctional protein with 3'-5' exoribonuclease activity and N7-83
MTase activity (24, 25). Nsp14-mediated N7-methylation of Gppp-RNA to form a cap-0 84 structure is a prerequisite for nsp10/16-mediated 2'O-methylation in vitro (13). A conserved 85
DxG motif within the MTase domain is required for SAM-binding in vitro, and alteration of 86 these residues abolishes MTase activity in vitro (13, 26) . However, the requirements of the CoV 87 nsp14 N7-MTase during viral replication are not known. Therefore, we assessed the effect of 88 mutations in the DxG motif of the MHV nsp14 N7-MTase on viral replication. We show that 89 alanine substitution of nsp14 D330 does not alter viral replication kinetics or increase sensitivity 90 to interferon-β treatment relative to wild-type (WT) MHV. However, alanine substitution of 91 nsp14 G332 impaired virus replication, resulting in delayed replication kinetics and decreased 92 peak titer, relative to WT MHV. In addition, nsp14 G332A virus displayed increased sensitivity 93 to treatment of cells with interferon-β, and nsp14 G332A genomes were translated less 94 efficiently in vitro and during infection. These data suggest that residue G332, but not residue 95 D330, is required for MHV nsp14 N7-MTase activity, and collectively, that the regulation of 96 6 CoV capping is likely more complex in the context of replicating virus than during in vitro 97 biochemical studies with isolated proteins. Bone-marrow-derived dendritic cells (BMDCs) were maintained in R10 medium (RPMI 1640 106
[Gibco] supplemented to contain 10% FBS, 2 mM L-glutamine, 100 μg/ml gentamicin [MP 107 Biomedicals], 0.25 µg/ml amphotericin B, 50 μM beta-mercaptoethanol, 20 ng/ml GM-CSF, and 108 10 ng/ml IL-4). Recombinant MHV strain A59 (GenBank accession number AY910861) was 109 propagated as described (28). 110 111 Cloning, recovery, and verification of mutant viruses. Site-directed mutagenesis was used to 112 engineer point mutations in individual MHV genome cDNA fragment plasmids using the MHV 113 infectious clone reverse genetics system (28). Viruses encoding firefly luciferase (FFL) fused to 114 nsp2 were recovered using MHV A frag-FFL2 (29). Mutant viruses were recovered using BHK-115 R cells following electroporation of in vitro-transcribed genomic RNA. All mutagenized 116 plasmids were sequenced (GenHunter Corporation, Nashville, TN) to ensure that no additional 117 mutations were introduced. Recovered viruses also were sequenced to verify the engineered 118 mutations. 119 Quantification of viral genomic RNA by qRT-PCR. An RNA standard was prepared using the 207 MHV A fragment (28) to generate a 931 nucleotide RNA. First, cDNA was generated by PCR 208 amplification using the primers: forward 5'-209 TAATACGACTCACTATAGGGGGCTATGTGGATTGTTGTGG-3', which initiates with a T7 210 promoter, and reverse 5'-AATTCTTGACAAGCTCAGGC-3'. RNA for the standard curve was 211 prepared using an mMessage mMachine T7 kit (Ambion) and purified using an RNeasy Mini kit 212 (Qiagen). A standard curve was generated using 10-fold dilutions from 10 3 to 10 8 copies. comparable to WT MHV (Fig. 1B) . Nsp14 D330A plaque morphology also was similar to that of 236 WT MHV (Fig. 1C) . In contrast, the nsp14 G332A virus began exponential replication 4-6 h 237 later than WT MHV and reached a lower peak titer (1.5 x 10 4 PFU/ml) relative to WT MHV (10 7 238 PFU/ml) (Fig. 1B) . The nsp14 G332A virus plaque size was also decreased relative to WT MHV 239 To determine the effect that increased sensitivity to IFN-β has on nsp14 G332A 291 replication, we tested whether nsp14 G332A virus replication could be rescued in BMDCs 292 lacking the IFN alpha/beta receptor (IFNAR -/-). IFNAR -/cells lack the capacity to respond to 293 type I IFNs and, thus, are incapable of mounting an effective IFN-dependent antiviral response 294 In addition to serving as a precursor for 2'O-methylation, N7-methylated guanosine 5' 321 caps are recognized by eIF4E and required for efficient translation of eukaryotic RNA (9, 37). 322
To determine whether the nsp14 G332A mutation impairs viral translation efficiency, we first 323 engineered virus encoding FFL as an in-frame N-terminal fusion with MHV nsp2 (29) in the 324
ORF1a polyprotein coding sequence of the isogenic nsp14 G332A cloned genome. In this 325 setting, FFL-nsp2 is the second protein translated from the input viral genome and becomes a 326 reporter for viral protein translation. We infected DBT cells with either WT-FFL or nsp14 327 G332A-FFL virus at an MOI of 0.1 PFU/cell, and lysates were prepared at various intervals post-328 infection to quantify luciferase activity and viral genome RNA copy number. Luciferase activity 329 accumulated more slowly following infection by nsp14 G332A-FFL virus relative to WT-FFL 330 virus (Fig. 5A ). WT-FFL signal began to decline after 16 h due to destruction of the cell 331 monolayer. In addition, levels of nsp14 G332A-FFL genomic RNA increased more slowly than 332 those of WT-FFL (Fig. 5B ). By quantifying both luciferase activity and viral genome copies, we 333 were able to calculate the kinetics of translation. To determine the rate of translation at each 334 time-point post-infection, the ratio of luciferase activity to genome copies was determined using 335 data from Figs. 5A and 5B. The ratio of luciferase activity to genome copies for WT-FFL was 336 highest at early times post-infection (Fig. 5C ). In contrast, the ratio of luciferase activity to 337 genome copies was substantially less for the nsp14 G332A-FFL virus at early time-points post-338 infection compared to WT-FFL and failed to reach peak WT-FFL levels. These data demonstrate 339 that nsp14 G332A-FFL virus requires more genomic RNA to achieve WT levels of FFL activity, 340 consistent with decreased translation efficiency of the mutant virus genome. Therefore, we next 341 on June 7, 2016 by UNIV OF NEBRASKA-LINCOLN http://jvi.asm.org/ Downloaded from determined whether nsp14 G332A-FFL and WT-FFL virions are equivalently infectious by 342 measuring the specific infectivity of each virus from infected DBT cell culture supernatants. The 343 ratio of nsp14 G332A-FFL particles per PFU was approximately 7-fold more than WT-FFL ( Fig.  344   5D ). Thus, packaged nsp14 G332A-FFL genomes were less efficient at establishing infection 345 than WT. 346 347 Nsp14 G332A-FFL genomes are translated less efficiently than WT-FFL genomes in vitro. 348
To directly assess the translation capacity of nsp14 G332A-FFL virus genomes, we isolated 349 genome RNA from purified virions. Increasing concentrations of genome RNAs were incubated 350 with rabbit reticulocyte lysates at 30°C for 1.5 h, and luciferase activity was quantified (Fig. 6A) . In this study, we engineered recombinant CoVs encoding alanine substitutions in the nsp14 N7-361
MTase at the SAM-binding site residues, D330 and G332. We found that the N7-MTase SAM-362 binding site mutants are viable and yield drastically different phenotypes during replication. 363
Specifically, MHV nsp14 D330A virus replicates indistinguishably from WT MHV in all assays 364 conducted, despite the requirement of this residue for SAM binding in vitro (26). There is 365 precedent for such a contradiction. A previous study using vesicular stomatitis virus identified a 366 SAM-binding residue within the L protein (G1674) that, when altered, does not affect viral 367 replication or N7-MTase activity (38). The structure of the SARS-CoV nsp10-nsp14 complex 368 reveals that D331 (D330 in MHV) is in close proximity to the SAM-binding site, but only G333 369 (G332 in MHV) directly contacts SAM (32) . Since in vitro N7-MTase activity was assessed only 370 for a SARS-CoV nsp14 D331A/G333A double mutant, it is not clear whether nsp14 D331 was 371 required for N7-MTase activity in this study (32) . However, a previous study using both in vitro 372 functional assays and yeast complementation reported that SARS-CoV nsp14 D331 is essential 373 for N7-MTase activity (26). Our study examined nsp14 N7-MTase in the context of viral 374 replication. A potential difference between our work and previous studies of the CoV nsp14 N7-375
MTase is the use of MHV versus SARS-CoV proteins, respectively. Purified MHV nsp14 N7-376
MTase is not available in our lab for biochemical studies. However, our results will guide future 377 experiments when such a system is established. During our study, we attempted to recover 378 SARS-CoV nsp14 D331A, I332A, and G333A N7-MTase mutant viruses. However, viable 379 viruses were not recovered after at least three attempts for each mutant. Nonetheless, the high 380 conservation of the SAM-binding residues makes it unlikely that the differences observed 381 between our work and previous biochemical studies are due to profoundly different N7-MTase 382 activity should result in a detectable change in 5-FU sensitivity, particularly since we performed 391 the assay using low-MOI conditions, which would increase mutagen incorporation during multi-392 step replication (31, 34). The lack of enhanced 5-FU sensitivity for the nsp14 D330A and nsp14 393 G332A viruses indicates that mutations at these SAM-binding residues do not significantly 394 dampen ExoN activity during virus replication. Additionally, since nsp14 G332A is resistant to 395 5-FU treatment, it is unlikely that the G332A phenotype is due to nsp14 instability or 396 degradation. 397
Our data indicate that impaired replication of nsp14 G332A virus is likely due to a 398 combination of factors, including increased detection by innate immune sensors and decreased 399 translation efficiency of viral RNA. Binding of type I IFNs to the IFN receptor leads to 400 expression of many IFN-stimulated genes and ultimately the establishment of an antiviral state 401 (39). Coronavirus RNAs lacking 2'O-methylation are sensed by IFIT1, which is one of the most 402 highly up-regulated IFN-stimulated genes following IFN induction (40). While nsp14 D330A 403 displayed WT-like sensitivity to pretreatment with IFN-β, nsp14 G332A virus did not replicate 404 following IFN-β pretreatment with doses greater than 75 U/ml. However, initial titers were lower 
